Lung Cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients diagnosed with advanced lung cancer (stage IIIb/IV or recurrent disease) and receiving anticancer drug therapy; patients with subjective dyspnea and a dyspnea score of 2 or higher on the breathlessness item of the questionnaire on ease of daily living at admission; patients scheduled for an outpatient visit approximately 2 weeks after discharge; age 20 years or older; able to provide written informed consent; and able to communicate in Japanese and participate in face to face interviews.
Exclusion criteria
Exclusion criteria: Patients judged to have difficulty expressing their intentions due to cognitive impairment or disturbance of consciousness. Patients judged to have marked difficulty participating in the study because of psychiatric disorders or acute psychological symptoms. Patients with severe comorbidities that are expected to cause acute exacerbation of dyspnea during the study period (e.g., acute exacerbation of interstitial lung disease or severe infection). Patients considered inappropriate for study participation by the attending physician or the principal investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in Self-Efficacy Scale for Advanced Cancer score | — |
Countries
Japan
Contacts
Tokai National Higher Education and Research System Gifu University School of Nursing